Evaluation of disintegration time and palatability of mitiglinide-voglibose combined orally disintegrating tablet.
Phase of Trial: Phase II
Latest Information Update: 05 Jul 2017
Price : $35 *
At a glance
- Drugs Mitiglinide/voglibose (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 30 Jun 2017 Status changed from recruiting to completed.
- 22 Feb 2017 New trial record